ANTARES PHARMA, INC. 4
4 · ANTARES PHARMA, INC. · Filed Mar 12, 2015
Insider Transaction Report
Form 4
Stacey Jennifer Evans
SVP, General Counsel & Secty
Transactions
- Award
Stock option (right to buy)
2015-03-10+47,000→ 47,000 totalExercise: $2.62Exp: 2025-03-09→ Common Stock (47,000 underlying)
Footnotes (2)
- [F1]Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan.
- [F2]The options vest in equal quarterly installments over one year beginning on March 10, 2015.